These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaginal concentrations of lactic acid potently inactivate HIV. Aldunate M; Tyssen D; Johnson A; Zakir T; Sonza S; Moench T; Cone R; Tachedjian G J Antimicrob Chemother; 2013 Sep; 68(9):2015-25. PubMed ID: 23657804 [TBL] [Abstract][Full Text] [Related]
5. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. Gong Z; Luna Y; Yu P; Fan H PLoS One; 2014; 9(9):e107758. PubMed ID: 25215504 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota. Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453 [TBL] [Abstract][Full Text] [Related]
7. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. O'Hanlon DE; Moench TR; Cone RA PLoS One; 2013; 8(11):e80074. PubMed ID: 24223212 [TBL] [Abstract][Full Text] [Related]
15. Why do lactobacilli dominate the human vaginal microbiota? Witkin SS; Linhares IM BJOG; 2017 Mar; 124(4):606-611. PubMed ID: 28224747 [TBL] [Abstract][Full Text] [Related]
16. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition. Hearps AC; Tyssen D; Srbinovski D; Bayigga L; Diaz DJD; Aldunate M; Cone RA; Gugasyan R; Anderson DJ; Tachedjian G Mucosal Immunol; 2017 Nov; 10(6):1480-1490. PubMed ID: 28401934 [TBL] [Abstract][Full Text] [Related]
17. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression. Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Zabihollahi R; Motevaseli E; Sadat SM; Azizi-Saraji AR; Asaadi-Dalaie S; Modarressi MH Daru; 2012 Oct; 20(1):53. PubMed ID: 23351891 [TBL] [Abstract][Full Text] [Related]
19. Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections. Avitabile E; Menotti L; Croatti V; Giordani B; Parolin C; Vitali B Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273118 [TBL] [Abstract][Full Text] [Related]
20. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. Breshears LM; Edwards VL; Ravel J; Peterson ML BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]